5-Bromo-2,3-dichloropyridine | CAS:97966-00-2

We serve 5-Bromo-2,3-dichloropyridine CAS:97966-00-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromo-2,3-dichloropyridine

Chemical Name:5-Bromo-2,3-dichloropyridine
CAS.NO:97966-00-2
Synonyms:5-Bromo-2,3-dichloropyridine
3-bromo-5,6-dichloropyridine
2,3-Dichloro-5-bromopyridine
5-bromo-2,3-dichloro-pyridine
 
Physical and Chemical Properties:
Density 1.8±0.1 g/cm3
Boiling Point 233.6±35.0 °C at 760 mmHg
Melting Point 35-37ºC
Molecular Formula C5H2BrCl2N
Molecular Weight 226.886
Flash Point 95.1±25.9 °C
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 5-Bromo-2,3-dichloropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-2,3-dichloro-pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-5,6-dichloropyridine Use and application,3-bromo-5,6-dichloropyridine technical grade,usp/ep/jp grade.


Related News: But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said.(E)-3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)acrylaldehyde manufacturer The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.5-fluoro-3-nitropyridin-2-amine supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.1-CYCLOPROPYL-6,7-DIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID vendor However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.